Skin Therapy Letter: Canadian Edition
Comprehensive Treatment Information for Canadian Dermatologists
Skin Care Guide - Canadian Edition
Skin Therapy Letter STL Family Practice STL Pharmacist STL Pediatric About STL Subscribe Today Dermatology Dictionary Skin Care Network

Indexed by the US National Library of Medicine and PubMed      

 

Index to Skin Therapy Letter - Volume 10 Articles, Issues 1-10

Articles are indexed by drug names, trade-names, and deases terms.
Drug Name     Issue#: Page# (bold entries refer to major references)

    A

Accutane®
Actinic Keratosis
Aczone®
Adalimumab
Agalsidase Alfa
Aldara®
Alefacept
Alesion® Dry Syrup 1%
AlloDerm®
AMEVIVE®
Anakinra
Antimicrobial Barrier Dressing
Antiviral
Arava®
Atopic Dermatitis
Avelox®

2:10
2:1-5
1:8;9:8
1:8;3:10;8:10;10:8
3:8
2:1-5;3:8;6:2-5
1:8;2:10;3:7
10:8
9:5-7
1:8;2:10;3:7
1:8
7:8
1:1-4
3:8
8:1-6
8:10

    B

Basal Cell Carcinoma
Betamethasone
Bextra®
BG-12
Blepharoplaasty
BOTOX®
Botulinum Toxin -Type A
Bovine Collagen

6:2-5
9:1-4
2:10
6:10
7:4-7
1:5-7;3:8
1:5-7;3:8
1:5-7;9:5-7

    C

Café au Lait Macules
Calcineurin Inhibitor
Calcipotriene
Canvaxin™
Cefdinir Oral Suspensions
CellCept®
Cellegesic®
Cetirizine HCL
Chin
Ciclopirox Nail Laquer
Clarinex®
Clindamycin
Clindamycin 1% +Tretinoin 0.25% Gel
Clinical Phototherapy System
Clobetasol Propionate
Cosmoderm®
Cosmoplast®
Corticosteroids
COX-2 Inhibitor
Cutter Advanced®
Cyproterone Acetate/Ethinyl Estradiol

8:7-9
8:1-6
9:1-4
7:8
1:8;3:7
3:1-6
1:8
3:7;4:8
6:6-9
7:1-3
3:7;9:8
3:7,10
2:10
3:8,10
9:1-4
1:5-7
1:5-7
9:1-4
2:10
8:10
6:10

    D

Dalbavancin
Dapsone Gel 5%
Dermatochalasis
Desloratadine
Diane-35®
Diclofenac/Hyaluronic Acid
Diptheria, Tetanus, Pertussis, Polio,
H Influenza Type B Vaccine
Dithranol
Dovobet®
Dry Skin

3:10;4:8
1:8;9:8
7:4-7
3:7;9:8
6:10
2:1-6

10:8
8:10
9:1-4
5:1-8

    E

Efalizumab
Eflornithine
Elidel®
Emollients
Enbrel®
Epinastine Hydrochloride
Etanercept
Evoclin®
Excision

3:7;10:8
9:8;10:1-4,8
3:10;4:1-3;5:12;8:1-6
5:1-8
3:7,8;7:8
4:8
3:7,8;7:8
3:7,10
4:4-7

    F

Facial Lipoatrophy
Famciclovir
Famvir®
Filler
5-Fluorouracil
Fluocinonide 0.1% Cream
Fumerate

5:9-11;9:5-7
10:5-7
10:5-7
1:5-7

2:1-6
4:8
6:10

    G

Genital Herpes
German Measles
Griseofulvin Oral Suspension USP

10:5-7
5:12
4:8

    H

HIV
Hair Dye
Hair Removal
Hemangiomas
Herpes Simplex
Herpes Virus
Herpes Zoster
Human Collagen
Human Immunodeficiency Syndrome
Humectants
HUMIRA®
Hyalite™
Hyaluronic Acid
Hylaform
Hylaform® Plus
Hylan-B Gel

5:9-11;9:5-7
6:10
10:1-4
8:7-9

1:1-4;10:5-7
1:1-4
10:5-7
1:8;9:5-7
5:9-11
5:1-8
1:8;3:10;8:10;10:8
3:7
1:5-7;3:7;9:5-7;10:8
1:5-7
1:5-7;2:10;3:7
2:10;3:7

    I

Imiquimod 5% Cream
Immune Response Modifier
Impavido®
Implant
Inflammatory Skin Disease
Infliximab
Injectable Poly-L-Lactic Acid
Isotretinoin

2:1-5;3:8;6:2-5
2:1-5
5:12
6:6-9;9:5-7
3:1-6
2:10;3:8;6:10;10:8
3:7
2:10

 

    J

Jowl

6:6-9

    K

Kineret®

1:8

    L

Labial Herpes
Lamisil®
Laser Treatment, Pediatric
Leflunomide

10:5-7
8:10
8:7-9
3:8

    M

MDX-010
Measles, Mumps, Rubella,
Varicella Vaccine
Melanoma
Meropenem for Injection
Merrem®
Metrogel®
Metronidazole
Miltefosine
Moisturizers
Moxifloxicin HCL
Mupriocin Ointment 2%
Mycophenolate Mofetil

3:8,10

9:8
5:12
7:8
7:8
9:8
9:8
5:12
5:1-8
8:10
10:8
3:1-6

    N

NASHA
Nitroglycerin Ointment

1:5-7
1:8

    O

Occlusives
Olanzapine
Olux® Foam
Omnicef®
Onercept
Onychomycosis
Otoplasty

5:1-8
4:8
9:1-4
1:8,3:7
7:8
7:1-3
2:7-9

    P

Pediatrics
Penlac®
Pentacel®
Permanent Fillers
Photodynamic Therapy
Picaridin
Pimecrolimus
Poly-L-Lactic Acid
Port Wine Stains
Prominent Ears
Protopic®
Psoriasis
Puragen®

8:7-9
7:1-3

10:8
9:5-7
2:1-6
8:10
3:10;4:1-3;5:12;8:1-6
5:9-11
8:7-9
2:7-9

3:10;4:1-3;5:12
9:1-4
10:8

    R

Raptiva®
Regenerative Tissue Matrix
Remicade®
Replegal®
Restylane®
Rubella

3:7;10:8
9:5-7
2:10;3:8;6:10;10:8
3:8
1:5-7;3:7
5:12

    S

Sculptra®
SGN-30
Sequential Therapy
Silikon™ 1000
Squamous Cell Carcinoma
Scars
Scar Revision
Sculptra®
Skin Cap®
Solaraze®
SonoPrep®
Surgical Scarring

3:7;9:5-7
3:8
9:1-4
9:5-7
2:1-5
4:4-7
4:4-7

5:9-11
8:10
2:1-6
1:8;3:8
3:9

    T

Tacrolimus
Tazarotene Capsules
Temporary Fillers
Terbinafine HCL
Tigecycline
Transconjunctival
Tygacil®

3:10;4:1-3;5:12
1:8
9:5-7
8:10
8:10
7:4-7
8:10

    U

Ultrasonic Skin Permeation Device
Unwanted Facial Hair

1:8;3:8
10:1-4

    V

Valacyclovir
Valtrex®
Vaniqa®
Vanos™
Varicella Zoster
Velac®

1:1-4
1:1-4

9:8;10:1-4,8
4:8
1:1-4
2:10

    Z

Zostavax®
Zoster Vaccine Live
Zyderm®
Zyplast®
Zyprexa®
Zyrtec®

7:8;9:8
7:8;9:8
1:5-7
1:5-7
4:8
3:7;4:8


  1. Etanercept for the Treatment of Psoriasis
  2. Reduction of Face and Neck Laxity With Anchored, Barbed Polypropylene Sutures (Contour Threads™)
  3. Update on Drugs and Drug News - February 2006
  4. Index to Skin Therapy Letter - Volume 10 Articles, Issues 1-10
Penlac® (Ciclopirox)

Close   |   Move

Click to view the entire Penlac® (Ciclopirox) presentation.
  • INTRODUCTION
    Penlac is the first topical anti-fungal preparation approved specifically for the treatment of onychomycosis. The product was available for use in Canada in...   |   Read more ...


  • DRUG
    Ciclopiroxs' mechanism of action is fungicidal by affecting intracellular metabolic processes reducing the organisms ability to process nutrients and detoxify toxic metabolites...   |   Read more ...


  • DELIVERY SYSTEM
    Ciclopirox is incorporated into a clear nail lacquer at an 8% concentration which is applied directly onto the nail plate.This transungual delivery system is unique allowing...   |   Read more ...


  • PHARMACOKINETICS
    The penetration of ciclopirox through the nail plate is well documented by invitro studies utilizing cow horn and sheep and bovine nailplate. Studies of penetration in human finger and...   |   Read more ...


  • APPLICATION TECHNIQUE
    Ciclopirox nail lacquer (Penlac) is applied evenly by brush to the entire nail plate including the undersurface at the distal end and at the sites of onycholysis...   |   Read more ...


  • CLINICAL EFFICACY
    The two pivotal US trials were double blind placebo controlled trials involving 549 patients randomized 1:1, placebo:drug who applied ciclopirox daily for 48 weeks to their great toenails...   |   Read more ...


  • SAFETY
    The data gathered from clinical trials and post-marketing reports have not shown any significant systemic side effects related to the topical application of Penlac nail lacquer...   |   Read more ...


  • PATIENT SELECTION
    In my experience, the patients most likely to have the best experience and be most successful with the use of Penlac are...   |   Read more ...

View the entire Penlac® (Ciclopirox) presentation.